Medtronic, Inc. (MDT) Reports In-Line Q4 EPS; Guides FY15
Get Alerts MDT Hot Sheet
Price: $95.41 -1.22%
Revenue Growth %: +5.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +5.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.58 billion.
Medtronic, Inc. sees FY2015 EPS of $4.00-$4.10, versus the consensus of $4.09. In fiscal year 2015, the company expects full-year revenue growth in the range of 3 to 5 percent on a constant currency basis.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Bristol Myers Squibb MS CAR T therapy data shows patients off DMTs
- Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share